Considerations for analysis of clinical samples

Close-up of colorful test tubes with blue caps in a laboratory setting.

When diagnostic tests are implemented in clinical studies there are multiple considerations beyond just the assay and the analyte that are not generally considered but are important. For example: Sample collection, preparation and transport

Standards need to be specified for pre-analysis that would specify the conditions needed even before the analysis are done.

Selection of tubes – The tubes that are used for collection can affect the analyte and need to be carefully considered

Timing of sample transit: How long does it take for the sample to arrive at the testing facility after collection from the patient

Storage: Storage of the samples during transit or even after the transit need to be clear and specified before it can be used.

There are other considerations for samples but this quickly illustrates that the sample journey should be considered in addition to assay parameters: such as limit of detection, thresholds for specificity and sensitivity, causes of interference and other assay specific parameters.

Similar Posts

  • |

    Causes of Death

    If you’re a billionaire, then you’ve got a lot of wealth and access to our resources. However, what you do not have is access to additional years of your life.There has been a wonderful Substack post about how billionaires die. It turns out that most of the death is due to aging and unspecified reasons,…

  • | |

    Hypertension

    There are many therapies for regulating high blood pressure. The one that has received some attention is the natural therapy by consumption of beet in various forms. Juice, raw, tablets, and cooked. The primary benefit appears to be conferred by the presence of nitrates, which enhance the amount of Nitric oxide present in blood and…

  • Biomarker databases

    Biomarker database There are several databases that are used to track biomarkers. The important thing to keep in mind is that the biomarker may be biological entity like a protein, lipid or DNA/RNA fragment but they can also be a group of cells – for example Tumor infiltrating cells or, physiological test, clinical outcome measure…

  • Multi-cancer early detection

    There have been so many multi-cancer early detection tests coming on the market and the users are generally not aware of them – each of them have a different capability and strengths. Genomeweb had done a survey of what are the tests available and how they are perceived. Look at the survey at : https://www.genomeweb.com/cancer/genomeweb-survey-enthusiasm-mced-tests-research-and-clinical-care-despite-evidence-caveats…